Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 5, 1998, Pages

  Montgomery, S A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Elderly; Serotonin reuptake inhibitor; Side effect

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME P450 ISOENZYME; DIURETIC AGENT; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENOTHIAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; AMNESIA; ANTICHOLINERGIC EFFECT; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DEPRESSION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; XEROSTOMIA;

EID: 0031660034     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199809005-00010     Document Type: Conference Paper

References (40)

1. Altamura AC, Percudani M, Guercetti G, Invemizzi G (1989). Efficacy and tolerability of fluoxetine in the elderly: a double blind study versus amitriptyline. Int Clin Psychopharmacol 4:103-106.
2. Amin MM, Ananth JV, Coleman BS et al. (1984). Fluvoxamine: antidepressant effect confirmed in a placebo controlled international study. Clin Neuropharm 7 (suppl 1):317-318.
3. Benfield P, Ward A (1986). Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:313-334.
4. Blazer D (1980). The diagnosis of depression in the elderly. J Am Geriatr Soc 28:52-58.
5. Buff D, Brenner R, Kirtane SS, Gilboa R (1991). Dysthymia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Psychiat 52:174-176.
6. Cohn CK, Shrivastava R, Mendel SJ et al. (1990). Double blind multicentre comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiat 51 (suppl 8):28-33.
7. Copeland JRM, Davidson IA, Dewey ME et al. (1992).Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 161:230-239.
8. Dorman T (1992). Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. Int Clin Psychopharmacol 6 (suppl 4):53-58.
9. Dunbar GC (1995). Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy. Pharmacology 51:127-144.
10. Dunner DL, Cohn JB, Walshe T et al. (1992). Two combined multi centre double blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiat 53 (suppl 2):57-60.
11. Evans ME, Lye M (1992). Depression in the elderly physically ill: an ages study of treatment with the 5HT reuptake inhibitor fluoxetine. J Clin Exper Geront 14:297-307.
12. Feighner JP, Cohn JB (1985). Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiat 46:20-25.
13. Fiebel JH, Springer CJ (1982). Depression and failure to resume social activities after stroke. Arch Phys Med Rehab 63:276-278.
14. Finkel S, Richter EM (1995). Double-blind comparison of setraline and nortriptyline in late-life depression. ECNP,
15. Fisch C (1985). Effect of fluoxetine on the electrocardiogram. J Clin Psychiat 46 (suppl 3):42-44.
16. Fredricson-Overo K, Toft B, Chrisopherson L, Gylding-Sabroe JP (1985). Kinetics of citalopram in elderly patients. Psychopharmacol 86:253-257.
17. Gottfries CG, Karlsson I, Nyth AL (1992). Treatment of depression in elderly patients with and without dementia disorders. Int Clin Psychopharmacol 6 (suppl 5):55-64.
18. Guillibert E, Pelicier Y, Archambault JL et al. (1989). A double blind multi centre study of paroxetine v clomipramine in depressed elderly patients. Acta Psychiatr Scand 80 (350):132-134.
19. Henry JA, Alexander CA, Sener EK (1995). Relative mortality from overdose of antidepressants. Br Med J 310:221-224.
20. Hutchinson DR, Tong S, Moon CAL, Vince M, Clarke A (1991). A double-blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. Br J Clin Res 2:43-57.
21. Jacoby R, Lunn MA, Ardem M et al. (1993). How long should the elderly take antidepressants? A double blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 162:175-182.
22. Jenner PN (1992). Paroxetine: an overview of dosage, tolerability, and safety. Int Clin Psychopharmacol 6 (suppl 4):69-80.
23. Johnson DAW (1981). Depression: treatment compliance in general practice. Acta Psychiatr Scand 63 (290):447-453.
24. Katz IR, Simpson GM, Curlik SM et al. (1990). Pharmacologic treatment of major depression for elderly patients in residential care settinss. J Clin Psychiatry 51:229-236.
25. Lemberger L, Bergstrom RF, Wolen RL, Farid NA, Enas GG, Aronoff GR (1985). Fluoxetine: Clinical pharmacology and physiologic disposition. J Clin Psychiat 46:14-19.
26. Molchan SE, Martinez RA, Hill JL et al. (1992). Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res Rev 46:20-25.
27. Montgomery SA (1989). The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 4 (suppl 1):113-119.
28. Montgomery SA, Dunner DL, Dunbar GC (1995). Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 5:5-13.
29. Nelson JC, Mazure CM, Jatlow PI (1994). Characteristics of desipramine-refractory depression. J Clin Psychiat 55:12-19.
30. Nielsen BM, Behnke K, Arup P et al. (1993). A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder. Acta Psychiatr Scand 87:269-272.
31. Nyth AL, Gottfries CG (1990). The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 157:894-901.
32. Nyth AL, Gottfries CG, Lyby K et al. (1992). A controlled multicentre clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 86:138-145.
33. Phanjoo A, Wonnacott S, Hodgson A (1991). Double blind comparitive multi center study of fluvoxamine and mianserin in the treatment of major depressive episode in the elderly. Acta Psychiatr Scand 83:476-479.
34. Rahman MK, Akhtar MJ, Savla NC et al. (1991). A double-blind randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract 45:255-258.
35. Ray WA, Griffin MR, Shaffner W et al. (1987). Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363-3439.
36. Roose SP, Glassman AH, Giardina EG et al. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychology 44:273-275.
37. Schone W, Ludwig M (1993). A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 13:34-39.
38. Silverstone PH (1990). Depression increases mortality and morbidity in acute life-threatening medical illness. J Psychosom Res 34:651-657.
39. Tollefson GD, Holman SJL (1993). Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Int Clin Psychopharmacol 8:253-259.
40. Wakelin JS (1986). Fluvoxamine in the treatment of the older depressed patient: double blind placebo controlled data. Int Clin Psychopharmacol 1:221-230.